Boccardi, Marina http://orcid.org/0000-0001-6744-8246
,
Festari, Cristina
Altomare, Daniele
Gandolfo, Federica
Orini, Stefania
Nobili, Flavio
Frisoni, Giovanni B.
Funding for this research was provided by:
European Association of Nuclear Medicine (n.a.)
European Academy of Neurology (n.a.)
Article History
Received: 11 April 2018
Accepted: 13 April 2018
First Online: 30 April 2018
Compliance with ethical standards
:
: Marina Boccardi has received funds from the European Association of Nuclear Medicine (EANM) to perform the evidence assessment and the global coordination of the present project. Moreover, she has received research grants from Piramal and served as a paid member of advisory boards for Eli Lilly.Cristina Festari: declares that she has no conflict of interest.Daniele Altomare was the recipient of the grant allocated by the European Academy of Neurology (EAN) for data extraction and evidence assessment for the present project.Federica Gandolfo: declares that she has no conflict of interest.Stefania Orini: declares that she has no conflict of interest.Flavio Nobili: received personal fees and non-financial support from GE Healthcare, non-financial support from Eli-Lilly and grants from Chiesi Farmaceutici.Giovanni B Frisoni is principal investigator of industry-sponsored trials funded by AbbVie, Acadia, Altoida, Amoneta, Araclon, Biogen, Janssen, Novartis, Piramal; has received funding for investigator-initiated trials from GE, Piramal, and Avid-Lilly; and has received speaker fees from a number of pharma and imaging companies.
: This is a review article that does not contain any original study with human participants performed by any of the authors. Ethical approval is shown in each of the quoted original papers.
: Not applicable to this review article. Informed consent statement is declared in each of the revised papers.